462 related articles for article (PubMed ID: 17980236)
1. Implementation of chlorhexidine gluconate for central venous catheter site care at Siriraj Hospital, Bangkok, Thailand.
Balamongkhon B; Thamlikitkul V
Am J Infect Control; 2007 Nov; 35(9):585-8. PubMed ID: 17980236
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness analysis of chlorhexidine gluconate compared with povidone-iodine solution for catheter-site care in Siriraj Hospital, Thailand.
Maenthaisong R; Chaiyakunapruk N; Thamlikitkul V
J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S94-101. PubMed ID: 17718250
[TBL] [Abstract][Full Text] [Related]
3. Vascular catheter site care: the clinical and economic benefits of chlorhexidine gluconate compared with povidone iodine.
Chaiyakunapruk N; Veenstra DL; Lipsky BA; Sullivan SD; Saint S
Clin Infect Dis; 2003 Sep; 37(6):764-71. PubMed ID: 12955636
[TBL] [Abstract][Full Text] [Related]
4. Prospective, randomized trial of two antiseptic solutions for prevention of central venous or arterial catheter colonization and infection in intensive care unit patients.
Mimoz O; Pieroni L; Lawrence C; Edouard A; Costa Y; Samii K; Brun-Buisson C
Crit Care Med; 1996 Nov; 24(11):1818-23. PubMed ID: 8917031
[TBL] [Abstract][Full Text] [Related]
5. Alcoholic povidone-iodine or chlorhexidine-based antiseptic for the prevention of central venous catheter-related infections: in-use comparison.
Girard R; Comby C; Jacques D
J Infect Public Health; 2012 Mar; 5(1):35-42. PubMed ID: 22341841
[TBL] [Abstract][Full Text] [Related]
6. Prospective randomized trial of 10% povidone-iodine versus 0.5% tincture of chlorhexidine as cutaneous antisepsis for prevention of central venous catheter infection.
Humar A; Ostromecki A; Direnfeld J; Marshall JC; Lazar N; Houston PC; Boiteau P; Conly JM
Clin Infect Dis; 2000 Oct; 31(4):1001-7. PubMed ID: 11049783
[TBL] [Abstract][Full Text] [Related]
7. Chlorhexidine-based antiseptic solution vs alcohol-based povidone-iodine for central venous catheter care.
Mimoz O; Villeminey S; Ragot S; Dahyot-Fizelier C; Laksiri L; Petitpas F; Debaene B
Arch Intern Med; 2007 Oct; 167(19):2066-72. PubMed ID: 17954800
[TBL] [Abstract][Full Text] [Related]
8. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis.
Chaiyakunapruk N; Veenstra DL; Lipsky BA; Saint S
Ann Intern Med; 2002 Jun; 136(11):792-801. PubMed ID: 12044127
[TBL] [Abstract][Full Text] [Related]
9. Comparison of Oligon catheters and chlorhexidine-impregnated sponges with standard multilumen central venous catheters for prevention of associated colonization and infections in intensive care unit patients: a multicenter, randomized, controlled study.
Arvaniti K; Lathyris D; Clouva-Molyvdas P; Haidich AB; Mouloudi E; Synnefaki E; Koulourida V; Georgopoulos D; Gerogianni N; Nakos G; Matamis D;
Crit Care Med; 2012 Feb; 40(2):420-9. PubMed ID: 21926583
[TBL] [Abstract][Full Text] [Related]
10. Comparison of 0.05% chlorhexidine and 10% povidone-iodine as cutaneous disinfectant for prevention of central venous catheter-related bloodstream infection: a comparative study.
Ishizuka M; Nagata H; Takagi K; Kubota K
Eur Surg Res; 2009; 43(3):286-90. PubMed ID: 19648751
[TBL] [Abstract][Full Text] [Related]
11. Prospective randomized trial of 3 antiseptic solutions for prevention of catheter colonization in an intensive care unit for adult patients.
Vallés J; Fernández I; Alcaraz D; Chacón E; Cazorla A; Canals M; Mariscal D; Fontanals D; Morón A
Infect Control Hosp Epidemiol; 2008 Sep; 29(9):847-53. PubMed ID: 18665819
[TBL] [Abstract][Full Text] [Related]
12. Reduction in catheter-related infections after switching from povidone-iodine to chlorhexidine for the exit-site care of tunneled central venous catheters in children on hemodialysis.
Paglialonga F; Consolo S; Biasuzzi A; Assomou J; Gattarello E; Patricelli MG; Giannini A; Chidini G; Napolitano L; Edefonti A
Hemodial Int; 2014 Oct; 18 Suppl 1():S13-8. PubMed ID: 25330826
[TBL] [Abstract][Full Text] [Related]
13. Translating evidence into practice to prevent central venous catheter-associated bloodstream infections: a systems-based intervention.
Young EM; Commiskey ML; Wilson SJ
Am J Infect Control; 2006 Oct; 34(8):503-6. PubMed ID: 17015155
[TBL] [Abstract][Full Text] [Related]
14. A randomized trial comparing povidone-iodine to a chlorhexidine gluconate-impregnated dressing for prevention of central venous catheter infections in neonates.
Garland JS; Alex CP; Mueller CD; Otten D; Shivpuri C; Harris MC; Naples M; Pellegrini J; Buck RK; McAuliffe TL; Goldmann DA; Maki DG
Pediatrics; 2001 Jun; 107(6):1431-6. PubMed ID: 11389271
[TBL] [Abstract][Full Text] [Related]
15. Pilot trial to compare tolerance of chlorhexidine gluconate to povidone-iodine antisepsis for central venous catheter placement in neonates.
Garland JS; Alex CP; Uhing MR; Peterside IE; Rentz A; Harris MC
J Perinatol; 2009 Dec; 29(12):808-13. PubMed ID: 19812587
[TBL] [Abstract][Full Text] [Related]
16. Central venous catheter infection in adults in acute hospital settings.
Jones CA
Br J Nurs; 2006 Apr 13-26; 15(7):362, 364-8. PubMed ID: 16723935
[TBL] [Abstract][Full Text] [Related]
17. Skin antiseptics used prior to intravascular catheter insertion.
Adams D; Elliot TS
Br J Nurs; 2007 Mar 8-21; 16(5):278-80. PubMed ID: 17505372
[TBL] [Abstract][Full Text] [Related]
18. Skin antisepsis with chlorhexidine-alcohol versus povidone iodine-alcohol, with and without skin scrubbing, for prevention of intravascular-catheter-related infection (CLEAN): an open-label, multicentre, randomised, controlled, two-by-two factorial trial.
Mimoz O; Lucet JC; Kerforne T; Pascal J; Souweine B; Goudet V; Mercat A; Bouadma L; Lasocki S; Alfandari S; Friggeri A; Wallet F; Allou N; Ruckly S; Balayn D; Lepape A; Timsit JF;
Lancet; 2015 Nov; 386(10008):2069-2077. PubMed ID: 26388532
[TBL] [Abstract][Full Text] [Related]
19. Central venous catheter-related bloodstream infections: improving post-insertion catheter care.
Shapey IM; Foster MA; Whitehouse T; Jumaa P; Bion JF
J Hosp Infect; 2009 Feb; 71(2):117-22. PubMed ID: 19013680
[TBL] [Abstract][Full Text] [Related]
20. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector.
Casey AL; Worthington T; Lambert PA; Quinn D; Faroqui MH; Elliott TS
J Hosp Infect; 2003 Aug; 54(4):288-93. PubMed ID: 12919759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
